61 related articles for article (PubMed ID: 21530201)
1. Advantage of biological over physical optimization in prostate cancer?
Dirscherl T; Alvarez-Moret J; Bogner L
Z Med Phys; 2011 Sep; 21(3):228-35. PubMed ID: 21530201
[TBL] [Abstract][Full Text] [Related]
2. Improving the performance of direct Monte Carlo optimization for large tumor volumes.
Alvarez-Moret J; Dirscherl T; Rickhey M; Bogner L
Z Med Phys; 2010; 20(3):197-205. PubMed ID: 20832007
[TBL] [Abstract][Full Text] [Related]
3. Benefit of using biologic parameters (EUD and NTCP) in IMRT optimization for treatment of intrahepatic tumors.
Thomas E; Chapet O; Kessler ML; Lawrence TS; Ten Haken RK
Int J Radiat Oncol Biol Phys; 2005 Jun; 62(2):571-8. PubMed ID: 15890602
[TBL] [Abstract][Full Text] [Related]
4. Superiority of equivalent uniform dose (EUD)-based optimization for breast and chest wall.
Mihailidis DN; Plants B; Farinash L; Harmon M; Whaley L; Raja P; Tomara P
Med Dosim; 2010; 35(1):67-76. PubMed ID: 19931018
[TBL] [Abstract][Full Text] [Related]
5. Simultaneous beam geometry and intensity map optimization in intensity-modulated radiation therapy.
Lee EK; Fox T; Crocker I
Int J Radiat Oncol Biol Phys; 2006 Jan; 64(1):301-20. PubMed ID: 16289912
[TBL] [Abstract][Full Text] [Related]
6. Comparison of direct machine parameter optimization versus fluence optimization with sequential sequencing in IMRT of hypopharyngeal carcinoma.
Dobler B; Pohl F; Bogner L; Koelbl O
Radiat Oncol; 2007 Sep; 2():33. PubMed ID: 17822529
[TBL] [Abstract][Full Text] [Related]
7. On the parameter describing the generalised equivalent uniform dose (gEUD) for tumours.
Søvik A; Ovrum J; Olsen DR; Malinen E
Phys Med; 2007 Dec; 23(3-4):100-6. PubMed ID: 17962057
[TBL] [Abstract][Full Text] [Related]
8. Fast direct Monte Carlo optimization using the inverse kernel approach.
Bogner L; Alt M; Dirscherl T; Morgenstern I; Latscha C; Rickhey M
Phys Med Biol; 2009 Jul; 54(13):4051-67. PubMed ID: 19502701
[TBL] [Abstract][Full Text] [Related]
9. Investigation of effective decision criteria for multiobjective optimization in IMRT.
Holdsworth C; Stewart RD; Kim M; Liao J; Phillips MH
Med Phys; 2011 Jun; 38(6):2964-74. PubMed ID: 21815370
[TBL] [Abstract][Full Text] [Related]
10. Treatment plan comparison between helical tomotherapy and MLC-based IMRT using radiobiological measures.
Mavroidis P; Ferreira BC; Shi C; Lind BK; Papanikolaou N
Phys Med Biol; 2007 Jul; 52(13):3817-36. PubMed ID: 17664579
[TBL] [Abstract][Full Text] [Related]
11. Dosimetric advantages of IMRT simultaneous integrated boost for high-risk prostate cancer.
Li XA; Wang JZ; Jursinic PA; Lawton CA; Wang D
Int J Radiat Oncol Biol Phys; 2005 Mar; 61(4):1251-7. PubMed ID: 15752907
[TBL] [Abstract][Full Text] [Related]
12. Role of the parameters involved in the plan optimization based on the generalized equivalent uniform dose and radiobiological implications.
Widesott L; Strigari L; Pressello MC; Benassi M; Landoni V
Phys Med Biol; 2008 Mar; 53(6):1665-75. PubMed ID: 18367795
[TBL] [Abstract][Full Text] [Related]
13. The feasibility of using Pareto fronts for comparison of treatment planning systems and delivery techniques.
Ottosson RO; Engstrom PE; Sjöström D; Behrens CF; Karlsson A; Knöös T; Ceberg C
Acta Oncol; 2009; 48(2):233-7. PubMed ID: 18752085
[TBL] [Abstract][Full Text] [Related]
14. EUD-based biological optimization for carbon ion therapy.
Brüningk SC; Kamp F; Wilkens JJ
Med Phys; 2015 Nov; 42(11):6248-57. PubMed ID: 26520717
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of the dosimetric impact of non-exclusion of the rectum from the boost PTV in IMRT treatment plans for prostate cancer patients.
Kassim I; Dirkx ML; Heijmen BJ
Radiother Oncol; 2009 Jul; 92(1):62-7. PubMed ID: 19278745
[TBL] [Abstract][Full Text] [Related]
16. A role for biological optimization within the current treatment planning paradigm.
Das S
Med Phys; 2009 Oct; 36(10):4672-82. PubMed ID: 19928099
[TBL] [Abstract][Full Text] [Related]
17. Comparison of biologically equivalent dose-volume parameters for the treatment of prostate cancer with concomitant boost IMRT versus IMRT combined with brachytherapy.
Pieters BR; van de Kamer JB; van Herten YR; van Wieringen N; D'Olieslager GM; van der Heide UA; Koning CC
Radiother Oncol; 2008 Jul; 88(1):46-52. PubMed ID: 18378028
[TBL] [Abstract][Full Text] [Related]
18. Dose escalation in prostate cancer using intensity modulated neutron radiotherapy.
Snyder M; Joiner MC; Konski A; Bossenberger T; Burmeister J
Radiother Oncol; 2011 May; 99(2):201-6. PubMed ID: 21620496
[TBL] [Abstract][Full Text] [Related]
19. The comparison of radiotherapy techniques for treatment of the prostate cancer: the three-field vs. the four-field.
Milecki P; Piotrowski T; Dymnicka M
Neoplasma; 2004; 51(1):64-9. PubMed ID: 15004663
[TBL] [Abstract][Full Text] [Related]
20. Direct aperture optimization of breast IMRT and the dosimetric impact of respiration motion.
Zhang G; Jiang Z; Shepard D; Zhang B; Yu C
Phys Med Biol; 2006 Oct; 51(20):N357-69. PubMed ID: 17019024
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
